Anaptysbio, Inc
ANAB
Revenue
43.11M
▲13.10M▲43.63%
3 Months ChangeAssets
483.83M
▼-9.58M▼-1.94%
3 Months ChangeLiabilities
412.97M
▲3.92M▲0.9571%
3 Months ChangeFree Cash Flow
-37.28M
▼-12.54M▼-50.67%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-14
Form 8-K
ID: 0001193125-24-200684
2024-08-05
Form 10-Q
ID: 0001370053-24-000041
2024-08-05
Form 8-K
ID: 0001370053-24-000039
2024-06-12
Form 8-K
ID: 0001370053-24-000029
2024-05-09
Form 10-Q
ID: 0001370053-24-000027
2024-05-09
Form 8-K
ID: 0001370053-24-000026
2024-03-11
Form 8-K
ID: 0001370053-24-000010
2024-01-05
Form 8-K
ID: 0001370053-24-000003
2023-11-27
Form 8-K
ID: 0001370053-23-000069
2023-11-02
Form 10-Q
ID: 0001370053-23-000065